Management of speech, language and communication difficulties in Huntington’s disease

Author:

Hamilton Alison1,Ferm Ulrika2,Heemskerk Anne-Wil34,Twiston-Davies Rita5,Matheson Kirsty Y6,Simpson Shiela A67,Rae Daniela8

Affiliation:

1. Department of Speech & Language Therapy, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK

2. DART – Centre for Augmentative & Alternative Communication & Assistive Technology Regional Rehabilitation Centre, Queen Silvia Children’s Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden

3. Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands

4. Department of Speech & Language Therapy, Huntington Centre, Topaz, Overduin, Katwijk, The Netherlands

5. Department of Speech & Language Therapy, Royal Hospital for Neurodisability, Putney, London, UK

6. Department of Clinical Genetics, NHS Grampian, Aberdeen, Scotland, UK

7. University of Aberdeen, Aberdeen, AB25 2ZA Scotland, UK

8. Department of Clinical Genetics, NHS Grampian, Aberdeen, Scotland, UK.

Abstract

SUMMARY Speech and language therapists play an important role in the management of communication difficulties in Huntington’s disease (HD). As the disease progresses the effectiveness of communication becomes increasingly compromised by a combination of changes in motor function, diminishing cognitive linguistic abilities and neuropsychiatric changes, such as depression and apathy. The complexities and challenges presented by communication breakdown in HD require comprehensive assessment and interventions that are responsive to the changing motor, cognitive and emotional needs of the individual. The European Huntington’s Disease Network Standards of Care Speech and Language Therapy Working Group has brought together expert speech and language therapists from across Europe to produce guidelines to improve the management of communication disorders for individuals with HD. The guidelines were developed with the aim of promoting timely and appropriate assessment and focused management throughout all stages of the disease. Literature was thoroughly searched and evaluated in an attempt to ensure that the guidelines are based on available evidence. However as there is a paucity of good-quality, high-level evidence the guidance is based predominantly on expert opinion and consensus. The provision of care varies widely between countries in Europe and the implementation of these guidelines aims to help improve the quality of care delivered to individuals with HD.

Publisher

Future Medicine Ltd

Subject

Neurology (clinical)

Reference36 articles.

1. Linguistic and cognitive supplementation strategies as augmentative and alternative communication techniques in huntington's disease: Case report

2. FolsteinSE.Huntington’s Disease. John Hopkins University Press, MD, USA (1989).

3. HarperPS.Huntington’s Disease. WB Saunders Company Limited, PA, USA (1996).

4. QuarrellOW.Huntington’s Disease – The Facts.(2nd Edition).Oxford University Press, UK (2008).

5. Selective neurodegeneration in Huntington's disease

Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3